XML 69 R58.htm IDEA: XBRL DOCUMENT v3.21.2
Segment Information (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Segment Information        
Net sales $ 10,223 $ 7,328 $ 20,679 $ 15,054
Operating Earnings 1,392 672 3,501 1,430
Amortization of intangible assets (504) (553) (1,013) (1,114)
Earnings from continuing operations before taxes 1,348 526 $ 3,391 1,159
Annual share-based awards recognized in first quarter (as a percent)     50.00%  
COVID-19 Test Manufacturing Network Restructuring Plan        
Segment Information        
Restructuring charges 499   $ 499  
Established Pharmaceutical Products        
Segment Information        
Net sales 1,180 1,013 2,250 2,057
Nutritional Products        
Segment Information        
Net sales 2,108 1,883 4,144 3,787
Diagnostic Products        
Segment Information        
Net sales 3,247 1,994 7,261 3,820
Medical Devices        
Segment Information        
Net sales 3,666 2,423 6,986 5,360
Other        
Segment Information        
Net sales 22 15 38 30
Total Reportable Segment Operating Earnings        
Segment Information        
Net sales 10,201 7,313 20,641 15,024
Operating Earnings 2,994 1,593 6,338 3,441
Total Reportable Segment Operating Earnings | Established Pharmaceutical Products        
Segment Information        
Net sales 1,180 1,013 2,250 2,057
Operating Earnings 220 206 389 387
Total Reportable Segment Operating Earnings | Nutritional Products        
Segment Information        
Net sales 2,108 1,883 4,144 3,787
Operating Earnings 490 474 957 933
Total Reportable Segment Operating Earnings | Diagnostic Products        
Segment Information        
Net sales 3,247 1,994 7,261 3,820
Operating Earnings 1,076 522 2,777 927
Total Reportable Segment Operating Earnings | Medical Devices        
Segment Information        
Net sales 3,666 2,423 6,986 5,360
Operating Earnings 1,208 391 2,215 1,194
Reconciling items        
Segment Information        
Corporate functions and benefit plans costs (132) (106) (246) (238)
Net interest expense (123) (125) (247) (246)
Share-based compensation (132) (115) (420) (348)
Amortization of intangible assets (504) (553) (1,013) (1,114)
Other, net $ (755) $ (168) $ (1,021) $ (336)